What did @surgeon.dr.hafiz.gulfam actually say?
Honestly? It's nearly impossible to tell. The transcript from this 686K-view video is almost entirely incoherent, cycling through disconnected phrases about education, relationships, and a single data point: "10% of body weight." There is no clear, reviewable medical claim here, which is its own kind of problem when a surgeon is posting to nearly a million viewers.
The only fragment with any clinical relevance is the reference to "10% of body weight," which appears to gesture at weight loss outcomes, likely in the context of GLP-1 receptor agonists given the video's categorization. But the surrounding sentences provide no context: no drug named, no mechanism explained, no patient population specified. The phrase arrives mid-sentence and then dissolves into "thank you."
When a credentialed surgeon posts health content that reaches hundreds of thousands of people, the standard for clarity should be higher than this. Viewers cannot make informed decisions based on content they cannot parse.
Does the science back this up?
If the "10% of body weight" figure refers to GLP-1 outcomes, the number itself is defensible but represents the lower end of what the evidence shows, and context matters enormously depending on which drug and which population you're talking about.
Semaglutide (Wegovy) at 2.4mg weekly produced mean weight loss of approximately 14.9% of body weight in the STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine), with about one-third of participants losing more than 20%. Tirzepatide (Zepbound) pushed that further: the SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) showed mean reductions of up to 22.5% at the highest dose. Liraglutide (Saxenda) is closer to the 5-8% range in real-world use.
So "10% of body weight" is a reasonable ballpark for semaglutide in average clinical conditions, but presenting it as a standalone number without naming the drug, dose, or duration strips out everything a patient actually needs to evaluate whether a treatment is appropriate for them.
What did they get wrong (or right)?
The 10% figure is not wrong in isolation. What's wrong is everything around it, specifically the absence of everything around it. No drug named. No dose. No duration. No mention of side effects, which for GLP-1 agonists include nausea, vomiting, gastroparesis risk, and the still-debated question of muscle mass loss alongside fat loss (Biancalana et al., 2023, Diabetes Care).
The rest of the transcript is not a medical claim at all. Phrases like "you can't go anywhere down" and "I'd like to have a better education than you would have in your life" are not extractable health statements. They may reflect a translation or transcription issue, but that doesn't reduce the responsibility of a creator posting under the title "surgeon" to ensure their content communicates something accurate and actionable.
There's also a regulatory concern worth naming directly. Posting a phone number for appointments alongside surgical hashtags and GLP-1 adjacent content, without visible disclosure of risks, informed consent language, or evidence of proper telehealth licensure, does not meet the standard of responsible medical content creation.
What should you actually know?
GLP-1 receptor agonists are legitimate, well-studied medications with meaningful clinical evidence behind them. But "10% of body weight" is not a promise, a guarantee, or even a typical result for every drug in this class. Results depend on which medication, what dose, how long you take it, whether you pair it with lifestyle changes, and your individual metabolic profile.
Before pursuing any GLP-1 therapy, you should be working with a licensed provider who reviews your full medical history, screens for contraindications (including personal or family history of medullary thyroid carcinoma or MEN2 syndrome, per FDA labeling), and monitors you over time. A phone number in a TikTok caption is not a clinical intake process.
If you're in Pakistan and considering bariatric surgery or weight management medication, the standards for informed consent and provider accountability still apply. A surgeon with a large social following is not automatically a trustworthy clinical source, especially when the content they post cannot be fact-checked because it cannot be understood.
- Ask any provider to name the specific drug, dose range, and expected timeline before agreeing to treatment.
- Request documentation of side effects in writing, not just a verbal summary.
- Verify that the platform or clinic you use is properly licensed in your jurisdiction.